Unique ID issued by UMIN | C000000044 |
---|---|
Receipt number | R000000084 |
Scientific Title | A phase II study of palliative treatment with metallic stents for inoperable malignant colorectal strictures. (JIVROSG-0206) |
Date of disclosure of the study information | 2005/08/06 |
Last modified on | 2012/09/21 13:22:06 |
A phase II study of palliative treatment with metallic stents for inoperable malignant colorectal strictures. (JIVROSG-0206)
Colorectal stent (JIVROSG-0206)
A phase II study of palliative treatment with metallic stents for inoperable malignant colorectal strictures. (JIVROSG-0206)
Colorectal stent (JIVROSG-0206)
Japan |
Inoperable malignant colorectal strictures.
Gastroenterology | Hepato-biliary-pancreatic medicine | Hematology and clinical oncology |
Gastrointestinal surgery | Hepato-biliary-pancreatic surgery | Breast surgery |
Obstetrics and Gynecology | Urology | Radiology |
Malignancy
NO
To evaluate the safety and efficacy of palliative treatment with metallic stents for inoperable malignant colorectal strictures.
Efficacy
Confirmatory
Explanatory
Phase II
Improvement of subjective symptoms at 1 day, 1,2 and 4 weeks after stenting.
Adverse events, improvement of abdominal radiography findings at 1 day, 1,2 and 4 weeks after stenting.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Maneuver |
A bare stent is placed in the stenotic portion of sigmoid colon or rectum caused by malignant tumor via the trans-anal route.
Not applicable |
Not applicable |
Male and Female
1) Symptomatic acute colonic obstruction due to unresectable malignant tumor of sigmoid colon or rectum.
2) Stenosis or obstruction of sigmoid colon or rectum confirmed by colography. The lesion confined within the lower margin more than 5cm distant from the anal ring, and the higher margin up to the level of the iliac crest.
3) No clinically definitive obstruction in upper gastrointestional tract other than sigmoid colon or rectal lesion.
4) Adequate cardiac, hepatic, renal, respiratory, and bone marrow functions.
5) Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 3.
6) Expected survival more than 4 weeks.
7) Written informed consent.
1) The operation for colostomy scheduled.
2) Stenting as the preoperative preparation for the resection.
3) Serious bleeding from the lesion.
4) Pregnancy.
33
1st name | |
Middle name | |
Last name | Yoshitaka Inaba |
Aichi Cancer Center
Department of Diagnostic Radiology
1-1, Kankoden, Chikusaku, Nagoya 464-8681, Japan
052-762-6111
1st name | |
Middle name | |
Last name | Yasuaki Arai |
JIVROSG, Coordinating Office
Division of Diagnostic Radiology, National Cancer Center Hospital
5-1-1,Tsukiji,Chuo-ku,Tokyo,104-0045,Japan
03-3542-2511
http://jivrosg.umin.jp/
jivrosgoffice@ml.res.ncc.go.jp
Japan Interventional Radiology in Oncology Study Group (JIVROSG)
Ministry of Health, Labour and Welfare
Japan
NO
2005 | Year | 08 | Month | 06 | Day |
http://jivrosg.umin.jp/
Partially published
http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=55&abstractID=30530
Technical success: 97.0% (32/33)
Clinical success (SE+ME, ≥2w): 81.8% (27/33)
Mortality within 30 days: 3 (progression of the primary disease)
Clinical failure due to the obstruction of other sites: 1
Stent removal from anal pain: 1
Adverse events (grade 2-3): diarrhea 12, pain 5, bleeding 1, dysuria 1
Completed
2002 | Year | 11 | Month | 30 | Day |
2003 | Year | 02 | Month | 01 | Day |
2007 | Year | 02 | Month | 01 | Day |
2007 | Year | 03 | Month | 01 | Day |
2007 | Year | 03 | Month | 01 | Day |
2007 | Year | 05 | Month | 01 | Day |
2005 | Year | 08 | Month | 06 | Day |
2012 | Year | 09 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000084